Washington Trust CO Vertex Pharmaceuticals Inc Transaction History

Washington Trust CO

$2.83 Billion
Q3 2024

A detailed history of Washington Trust CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Washington Trust CO holds 801 shares of VRTX stock, worth $374,972. This represents 0.01% of its overall portfolio holdings.

Number of Shares

801

Previous 801 -0.0%

Holding current value

$374,972

Previous $375,000 0.8%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	BUY	$392.81 - $485.53 $26,318 - $32,530	67 Added 9.13%	801 $375,000
Q1 2024 Apr 23, 2024	BUY	$407.69 - $446.08 $17,530 - $19,181	43 Added 6.22%	734 $306,000
Q4 2023 Jan 18, 2024	BUY	$343.0 - $410.68 $20,580 - $24,640	60 Added 9.51%	691 $281,000
Q2 2023 Jul 27, 2023	BUY	$314.42 - $351.91 $2,829 - $3,167	9 Added 1.45%	631 $222,000
Q1 2023 May 10, 2023	BUY	$283.23 - $323.1 $175,885 - $200,645	621 Added 62100.0%	622 $195,000
Q1 2023 May 04, 2023	SELL	$283.23 - $323.1 $175,885 - $200,645	-621 Reduced 99.84%	1 $196,000
Q3 2022 Oct 14, 2022	BUY	$273.83 - $305.53 $82,149 - $91,658	300 Added 93.17%	622 $180,000
Q1 2022 May 05, 2022	BUY	$221.42 - $260.97 $67,090 - $79,073	303 Added 1594.74%	322 $84,000
Q4 2021 Feb 09, 2022	SELL	$177.01 - $223.45 $885 - $1,117	-5 Reduced 20.83%	19 $4,000
Q3 2021 Nov 09, 2021	BUY	$181.39 - $202.99 $906 - $1,014	5 Added 26.32%	24 $4,000
Q2 2021 Aug 05, 2021	SELL	$187.49 - $221.1 $749 - $884	-4 Reduced 17.39%	19 $4,000
Q1 2021 Apr 28, 2021	BUY	$207.02 - $241.31 $414 - $482	2 Added 9.52%	23 $5,000
Q3 2020 Nov 05, 2020	BUY	$255.65 - $303.1 $1,278 - $1,515	5 Added 31.25%	21 $6,000
Q1 2020 May 07, 2020	BUY	$199.77 - $247.81 $3,196 - $3,964	16 New	16 $4,000
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $2,180 - $2,505	-13 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$145.72 - $169.96 $1,894 - $2,209	13 New	13 $2,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.

Account

Washington Trust CO Vertex Pharmaceuticals Inc Transaction History